Generex Biotechnology Corporation - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 45 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Generex Biotechnology Corporation - Product Pipeline Review - 2014" provides data on the Generex Biotechnology Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Generex Biotechnology Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Generex Biotechnology Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Generex Biotechnology Corporation - Brief Generex Biotechnology Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Generex Biotechnology Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Generex Biotechnology Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Generex Biotechnology Corporation's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Generex Biotechnology Corporation's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Generex Biotechnology Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Generex Biotechnology Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Generex Biotechnology Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Generex Biotechnology Corporation and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Generex Biotechnology Corporation Snapshot 5
Generex Biotechnology Corporation Overview 5
Key Information 5
Key Facts 5
Generex Biotechnology Corporation - Research and Development Overview 6
Key Therapeutic Areas 6
Generex Biotechnology Corporation - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Generex Biotechnology Corporation - Pipeline Products Glance 11
Generex Biotechnology Corporation - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Generex Biotechnology Corporation - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Generex Biotechnology Corporation - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Generex Biotechnology Corporation - Drug Profiles 15
insulin human 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
AE-37 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
metformin hydrochloride 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
AE-AI Vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AE-H Vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AE-IG Vaccine 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AE-M Vaccine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
AE-O Vaccine 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
fentanyl 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Low Molecular Weight Heparin 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
morphine sulfate 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Generex Biotechnology Corporation - Pipeline Analysis 28
Generex Biotechnology Corporation - Pipeline Products by Therapeutic Class 28
Generex Biotechnology Corporation - Pipeline Products by Target 30
Generex Biotechnology Corporation - Pipeline Products by Route of Administration 31
Generex Biotechnology Corporation - Pipeline Products by Molecule Type 32
Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action 33
Generex Biotechnology Corporation - Recent Pipeline Updates 34
Generex Biotechnology Corporation - Company Statement 40
Generex Biotechnology Corporation - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 45
Disclaimer 45

List of Tables
Generex Biotechnology Corporation, Key Information 5
Generex Biotechnology Corporation, Key Facts 5
Generex Biotechnology Corporation - Pipeline by Indication, 2014 8
Generex Biotechnology Corporation - Pipeline by Stage of Development, 2014 9
Generex Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 10
Generex Biotechnology Corporation - Phase III, 2014 11
Generex Biotechnology Corporation - Phase II, 2014 12
Generex Biotechnology Corporation - Phase I, 2014 13
Generex Biotechnology Corporation - Preclinical, 2014 14
Generex Biotechnology Corporation - Pipeline by Therapeutic Class, 2014 29
Generex Biotechnology Corporation - Pipeline by Target, 2014 30
Generex Biotechnology Corporation - Pipeline by Route of Administration, 2014 31
Generex Biotechnology Corporation - Pipeline by Molecule Type, 2014 32
Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action, 2014 33
Generex Biotechnology Corporation - Recent Pipeline Updates, 2014 34
Generex Biotechnology Corporation, Subsidiaries 43